Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Madrigal Pharmaceuticals
Biotech
Akero's NASH miss drags a few peers down, spurring deja vu
Things were going pretty well in the NASH landscape, but yesterday the space came crashing back down to reality with the failure of Akero’s med.
Annalee Armstrong
Oct 11, 2023 10:50am
Madrigal COO departs days after new CEO starts—Chutes & Ladders
Sep 29, 2023 9:30am
Madrigal snags Sanofi exec as CEO—Chutes & Ladders
Sep 15, 2023 9:30am
FDA gives Madrigal's NASH drug priority review, no AdComm
Sep 13, 2023 10:50am
Madrigal's stock shaken by CEO change up ahead of NASH decision
Sep 11, 2023 10:52am
Prospective NASH market flips from failure to overcrowded
Aug 10, 2023 6:00am
